About
Zion Medical is an established scientific research company in the field of AIDS and cancer research. The company developed a new experimental drug, Gammora, which contains peptides derived from HIV that promote infected cells into self-induced death (apoptosis) and lentivirus manipulation in the case of cancer therapy. An investigational medicinal product, Gammora is a synthetic peptide compound derived from the HIV enzyme integrase, which is responsible for inserting the virus's genetic material into the DNA of the infected cell. Gammora stimulates the integration of multiple HIV DNA fragments into the host cell's genomic DNA, to an extent that triggers the self-destruction of the infected cell.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Zion Medical's primary focus in scientific research?
- Zion Medical is an established scientific research company primarily focused on AIDS and cancer research.
- What is the name of the experimental drug developed by Zion Medical?
- Zion Medical developed an experimental drug named Gammora.
- What is the mechanism of action for Zion Medical's drug Gammora?
- Gammora, an investigational medicinal product, is a synthetic peptide compound derived from the HIV enzyme integrase. It stimulates the integration of multiple HIV DNA fragments into the host cell's genomic DNA, triggering the self-destruction of the infected cell.
- When was Zion Medical founded?
- Zion Medical was founded in September 2014.
- What is the current operational status of Zion Medical?
- Zion Medical is currently inactive, having ceased operations in October 2021.
- Where is Zion Medical headquartered?
- Zion Medical is headquartered in Rehovot, Israel.
- How many employees did Zion Medical have?
- Zion Medical had 4 employees.
- What was Zion Medical's primary product?
- Zion Medical's primary product was Gammora.
- In what stage was Zion Medical's product Gammora?
- Gammora was in the clinical trial stage.
- Did Zion Medical conduct human clinical trials for Gammora?
- Yes, Zion Medical announced results of the first human clinical trial for its HIV drug Gammora in October 2018.